AHLYNA Pte Ltd is a sister company of SYMOGEN LIMITED an international service provider in all aspects of pharmacovigilance; Data Analytics & RWD&E, Medical writing & healthcare communication; Clinical & Medical Affairs; Regulatory & QA & Project Management services. Established in 2023, AHLYNA supports pharmaceutical, biotech, vaccines, medical device, generics/biosimilars/OTC & cosmetic companies in the APAC region and worldwide.
Our client speak very highly of us. We have an impeccable track record of high quality and consistent project delivery as we take pride in having a very deep understanding of the project requirements. Our strength lies in the experience and training of our teams spread across our UK and US offices. Clients are allocated specific teams, and depending on specific requirements, the teams can be involved in case processing, reconciliation, reporting, aggregate report production, medical review writing and other PV activities.
With offices in 2 major continents, our reach is global. We are also a culturally aware team of professionals who are extremely adept at building relationships globally while keeping the local nuances in mind.
Time means money for our client. We are an extremely time conscious organization and totally understand the challenging time constraints that our partner organizations face in a strong regulatory environment. In fact, on areas like case processing, we have a strong ability to scale up our talent pool to meet any unexpected surge in case volumes.